Enteral supplementation with arachidonic and docosahexaenoic acid and pulmonary outcome in extremely preterm infants.

Childhood morbidity derived from preterm birth is one of the most common causes of long-term sequelae in middle and high-income countries [1]. In infants born before 29 weeks of gestation, the lung disease bronchopulmonary dysplasia (BPD) affects nearly every second individual and the incidence has been unchanged or even increased, despite other improvements in preterm care [2 –4]. Lung damage coupled to BPD may have life-long consequences on respiratory health in this population [5,6].

Source: Prostaglandins, Leukotrienes and Essential Fatty Acids - February 13, 2024 Category: Biomedical Science Authors: Dirk Wackernagel, Anders K. Nilsson, Ulrika Sj öbom, Ann Hellström, Susanna Klevebro, Ingrid Hansen-Pupp Tags: Original research article Source Type: research